Showing results (451-460 of 570) with videos related to

Sort By:
Pageof 57
Critical Care Medicine|December 26, 2013
Infection hospitalization increases risk of dementia in the elderlyJudith A Tate, Beth E Snitz, Karina A Alvarez, et al.
Critical Care Medicine|May 21, 2019
Monocyte Distribution Width: A Novel Indicator of Sepsis-2 and Sepsis-3 in High-Risk Emergency Department PatientsElliott D Crouser, Joseph E Parrillo, Christopher W Seymour, et al.
Critical Care Medicine|November 27, 2013
Acquiring procedural skills in ICUs: a prospective multicenter study*Damien Roux, Jean Reignier, Guillaume Thiery, et al.
Frontiers in Immunology|October 17, 2022
Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysisMaria Julia Ruiz, Gabriel Siracusano, Andréa Cottignies-Calamarte, et al.
BMJ Open|October 23, 2025
Maximizing Extubation Outcomes Through Educational and Organizational Research (METEOR) Trial: protocol for a batched, stepped-wedge, cluster-randomised, type 2 hybrid effectiveness-implementation trialNiall T Prendergast, Jeremy M Kahn, Derek C Angus, et al.
JAMA Network Open|August 8, 2019
Long-term Host Immune Response Trajectories Among Hospitalized Patients With SepsisSachin Yende, John A Kellum, Victor B Talisa, et al.
JCI Insight|December 15, 2020
A road map from single-cell transcriptome to patient classification for the immune response to traumaTianmeng Chen, Matthew J Delano, Kong Chen, et al.
JAMA|July 26, 2018
Association Between the New York Sepsis Care Mandate and In-Hospital Mortality for Pediatric SepsisIdris V R Evans, Gary S Phillips, Elizabeth R Alpern, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|April 18, 2018
Traumatic Brain Injury and Infectious Encephalopathy in Children From Four Resource-Limited Settings in AfricaEricka L Fink, Amelie von Saint Andre-von Arnim, Rashmi Kumar, et al.
Critical Care Medicine|February 13, 2019
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)Richard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Pageof 57